Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Clinical Isolates of Rare Non-tuberculous Mycobacteria

PROVIDER: PRJNA844011 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR19451410.fastq.gz	Fastqsanger.gz
	SRR19451411.fastq.gz	Fastqsanger.gz
	SRR19451412.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Mycobacterium spp.

Project description:Clinical isolates of Non-tuberculous Mycobacteria Genome sequencing and assembly

| PRJNA319839 | ENA

Project description:Complete genome sequences of non-tuberculous Mycobacteria

| PRJNA799200 | ENA

Mycobacteroides abscessus

Project description:Sequencing of clinical non-tuberculosis Mycobacteria (NTM) isolates

| PRJNA669041 | ENA

Project description:Deeplex Myc-TB evaluation: Non-tuberculous mycobacteria (NTM)

| PRJNA633380 | ENA

Mycobacterium gordonae strain:Non-tuberculous Mycobacteria

Project description:Mycobacterium gordonae strain:Non-tuberculous Mycobacteria Genome sequencing

| PRJNA804378 | ENA

CIMENT

Project description:Epidemiology and Clinical Characteristics of Non-Tuberculous Mycobacteria Infections in Cystic Fibrosis Patients. (CIMENT)

| PRJEB73796 | ENA

NTMscope

Project description:Short-read whole genome sequencing of non-tuberculous mycobacteria

| PRJEB70863 | ENA

Mycobacterium

Project description:Sequence and Analysis of Non-tuberculous Mycobacteria (NTM) strains

| PRJNA305922 | ENA

Spectinomycin Analogs for the Treatment of Mycobacterium abscessus Infections

Project description:Non-tuberculous mycobacteria (NTM) are emerging pathogens with high intrinsic drug resistance. Among rapidly growing NTM species, Mycobacterium abscessus is among the most pathogenic. Standard of care therapy has led to unacceptable outcomes and demonstrates the urgent need to develop effective, broad-spectrum antimycobacterial regimens. Through synthetic modification of spectinomycin (SPC), an aminocyclitol antibiotic, we have identified a distinct structural subclass of ethylene linked aminomethyl spectinomycins (eAmSPC) that are up to 64-fold more potent against M. abscessus when compared to SPC. Lead eAmSPC retain activity against other NTM species and multi-drug resistant M. abscessus clinical isolates. Sequencing of eAmSPC-resistant mutants revealed nucleotide changes in the distinct helix-34 spectinomycin binding site and X-ray crystallography further demonstrated the derivatives mode of ribosomal inhibition remained on target. The eAmSPC displayed increased intracellular accumulation compared to SPC and transcriptional profiling indicate that eAmSPC’s induce whiB7 resistance responses, however, the series maintains potency despite its expression. These leads display favorable pharmacokinetic profiles and robust efficacy in M. abscessus mouse infection models. The results of these studies suggest that eAmSPCs have the potential to be developed into clinical treatments for M. abscessus and other NTM infections.

2023-01-09 | GSE222081 | GEO

Mycobacterium

Project description:Comprehensive identification of non-tuberculous mycobacteria and prediction of macrolide resistance

| PRJDB12894 | ENA